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 Abstract
Aim: to find out the relationship, if any, between the extent of the overall genomic DNA methylation, and clinical and 
pathological features of the sporadic endometrial adenocarcinomas in women.





 and twelve G
3
 tumors.
Methods: m5dC level was estimated after enzymatic digestion of DNA into nucleotides, 32P-postlabelling, two-
dimensional thin-layer chromatography on cellulose plates and phosphorobioimaging. The overall m5dC of the 
uterine cancer DNAs expressed as a ratio: (pm5dC/pm5dC+pdC) x 100% was compared to results obtained for 
parallel investigated but published earlier normal human endometrium DNAs.
Results: mean total cancer DNA methylation (3.48±0.46%) was significantly higher than that of the normal 
proliferative endometrium (2.94±0,4%, p=0.003) and lower than that of the secretory endometrium DNAs 
(3.75±0,47%, p=0.03). Among all endometrial cancer DNAs six were found to be hypomethylated, eight were 
hypermethylated, whereas the remaining 30 had m5dC within range of normal endometrium. Total DNA methylation 
was significantly higher in poorly differentiated (G
3
) than in lower grade neoplasms (3.94±0.46 vs. 3.3 ±0.32 %, 
p=0.025). Lower levels of DNA methylation seemed to be associated with diminished tumor invasiveness. 
Conclusions: our results suggest that alterations in overall DNA methylation seem to be a result of neoplastic 
transformation and could therefore be used as a prognostic molecular marker of endometrial cancer. 
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Introduction
	 DNA	 methylation	 is	 an	 enzymatic,	 epigenetic	
modification,	which	is	restricted	to	cytosine	residues	at	carbon-5	
of	the	pyrimidine	ring	[1].	Recent	evidences	implicate	the	DNA	
methylation	 in	 the	 regulation	 of	 gene	 expression,	 in	 genomic	
imprinting,	 in	 inherited	 diseases	 (e.g.	 fragile-X	 syndrome),	 in	
distinguishing	host	DNA	from	foreign	DNA,	and	in	oncogenesis	
[2,	3].	
	 Alterations	 in	 DNA	 methylation	 are	 among	 the	 most	
common	 and	 earliest	 events	 associated	 with	 neoplasia	 [1].	 It	








as	 compared	with	 normal	 tissues	 and	 benign	 tumors	 [6].	They	
also	noted	 large	differences	 in	overall	DNA	methylation	 in	 the	
same	 histological	 type	 of	 neoplasm,	 potentially	 due	 to	 grade	
of	 the	 tumor	or	 contamination	of	 the	 investigated	 sample	with	
the	 normal	 cells.	 Bernardino	 et	 al.	 believe	 that	 variations	 of	
hypomethylation,	which	 is	 a	 consistent	 characteristic	 of	 breast	
cancer,	may	not	correlate	with	tumor	progression	[7].	
	 However,	Soares	et	al.	found	that	 in	such	cancer	there	is	
a	 statistically	 significant	 correlation	 between	 the	 global	 DNA	
methylation	 and	 the	 disease	 stage,	 tumor	 size	 and	 histological	
grade	of	malignant	neoplasms	[8].	




demethylation	 level	 is	 closely	 correlated	 with	 the	 biological	
characteristic	of	liver	cancer	being	more	significant	in	cases	with	
tumor	infiltration	and	metastasis	[9].	
	 Moreover,	 the	 degree	 of	 reduced	DNA	methylation	was	
related	to	late	histopathological	hepatocellular	carcinoma	(HCC)	





any	 change	 of	 overall	DNA	methylation	 in	 a	 case	 of	 prostatic	
cancers	spreading	by	metastasis	[11].
	 Popiela	 et	 al.	 discovered	 that	 endometrial	 cancers	 in	
women	 contain	 higher	 grade	 of	 total	 DNA	 methylation	 level	
than	 those	 estimated	 in	 normal	 or	 preneoplastic	 endometrium	






of	 cancers	 on	 the	 levels	 of	 DNA	 methylation	 will	 provide	 a	
convenient	way	to	assess	a	tumor’s	biologic	aggressiveness	and	
to	predict	patient	outcome	[15].	
	 Therefore,	 the	 aim	 of	 our	 study	 was	 to	 find	 out	 the	












Cel pracy: poszukiwanie zależności między poziomem globalnej metylacji DNA, a niektórymi histologicznymi i 
klinicznymi cechami gruczolakoraków błony śluzowej macicy u kobiet.
Materiał i metody: odsetek 5-metylocytozyny (m5dC) zbadano przy zastosowaniu metody 32P-postlabeling oraz 
dwukierunkowej chromatografii cienkowarstwowej (TLC 2-D) z kwantyfikacją radioaktywności nukleozasad przy za-
stosowaniu czytnika BAS 2000 w próbkach wysokooczyszczonych preparatów genomowego DNA wyizolowanego 




 i dwunastu G
3
). Wyliczony według wzoru: [(m5dC/ m5dC+dC) x 100] poziom 
zmodyfikowanej zasady korelowano z wiekiem chorych, odróżnicowaniem mikroskopowym guza oraz głębokoś-
cią naciekania błony mięśniowej ścian macicy przez nowotwór. Poziom globalnej metylacji DNA w nowotworach 
przeanalizowano ponadto w relacji do uzyskanych równolegle, ale już opublikowanych, wyników badań stopnia 
metylacji w prawidłowym endometrium.
Wyniki: średni poziom globalnej metylacji DNA w gruczolakorakach endometrium (3,48±0,46%) był wyższy niż 
zanotowano we wzrostowej (p= 0,003) i niższy niż stwierdzono w wydzielniczej błonie śluzowej macicy (p=0,03). 
Hipometylację stwierdzono w 6, podczas gdy hipermetylacja genomowego DNA wystąpiła w ośmiu nowotwo-
rach. Średnia, globalna metylacja guzów w stopniu G
3
 była wyższa niż odnotowano w pozostałych (3,94±0,46 vs 
3,3±0.32 %, p=0,025). Stwierdzono narastanie poziomu zmodyfikowanego DNA w relacji do stopnia naciekania 
ścian macicy przez nowotwór.
Wnioski: uzyskane wyniki wskazują, że zmiany metylacji cytozyny mogą być raczej skutkiem stopnia transformacji 
nowotworowej endometrium u kobiet, a nie przyczyną wystąpienia gruczolakoraka.
 Słowa kluczowe: gruczolakorak / metylacja DNA / 
                  / epidemiologia molekularna / 
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	 Tissues	 were	 collected	 in	 the	 operating	 theater	 under	 a	
dissecting	microscope	by	a	punch	biopsy	of	 the	clearly	visible	
uterine	malignancy	 after	 dissection	 of	 the	 excised	 uterus.	 The	
tissue	 samples	were	 immediately	 frozen	 in	 liquid	nitrogen	 and	
stored	at	-80ºC	until	DNA	extraction	was	performed.	Each	tissue	
specimen	was	evaluated	at	the	Department	of	Pathology.	Cancer	




the	 Institute	 de	Biologie	Moléculaire	 et	Cellulaire,	 Strasbourg,	
France.





[32P]	 pdC	was	measured	 by	 bio-imaging	 analyzer	 (BAS	 2000,	
Fuji).	 The	 pm5dC	 content	 was	 expressed	 as	 a	 ratio:	 (pm5dC/
pm5dC+pdC)	x	100%.	Each	value	was	calculated	from	counting	
of	 two	 separate	 DNA	 preparations	 of	 each	 individual	 tissue	
specimen.	
	 Statistical	 analysis	 was	 performed	 using	 the	 Statistica	 8	
package.	Descriptive	statistics	were	summarized	by	calculating	
mean	 values,	 standard	 deviations	 and	 ranges.	 The	 comparison	
of	m5dC	 content	 between	 tissues	 groups	was	 based	 on	 a	 non-
parametric	Mann-Whitney	U	test	or	Wald-Wolfowitz	Runs	test,	
when	 appropriate.	A	 p	 value	 less	 than	 0.05	was	 considered	 as	
significant.
Results
	 We	 have	 previously	 demonstrated	 that	 the	 overall	 DNA	
methylation	in	the	normal	human	endometrium	depends	on	the	
menstrual	cycle	phase	[16].	DNA	methylation	was	significantly	
lower	 in	 the	 proliferative	 than	 in	 the	 secretory	 endometrium	
samples.	Therefore,	we	have	compared	the	results	of	DNA	m5dC	





significantly	 higher	 than	 the	 total	 m5dC	 in	 the	 proliferative	
endometrium	 (p=0.003),	 but	 it	 was	 significantly	 lower	 than	 in	
DNA	from	the	secretory	endometrium	(p=0.03).
	 The	 individual	 uterine	 cancer	 DNAs	 were	 considered	
hypomethylated	 if	 the	 m5dC	 values	 were	 below	 the	 mean	
for	 normal	 proliferative	 endometrium	 (2.94%±0.40%),	 or	
hypermethylated	when	the	percentage	of	the	m5dC	was	above	the	
mean	value	of	the	secretory	endometrium	(3.75%±0.47%).




























	 In	 all	 uterine	 cancers	 investigated	 the	 overall	 DNA	
















with	 hypermethylated	 DNA	 were	 all	 associated	 with	 deep	





Figure 1. Mean overall m5dC in less dedifferentiated (G1 and G2) and G3 sporadic 
adenocarcinomas in women (* - p<0.05).
 
Figure 2. Mean total m5dC content in endometrial adenocarcinomas according to 
infiltration of myometrium: NI - cancer confined to endometrial mucosa,  
<1/2- infiltration less than one half of uterine wall, >1/2- infiltration more than one half 
of uterine wall thickness. 
*- p<0.05; **- p<0.04 (Wald-Wolfowitz Runs test).
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than	one	half	of	uterine	wall	thickness	(3.29±0.33	vs.	3.62±0.55%,	
p<0,05).	Higher	mean	of	m5dC	level	in	such	cancers	in	relation	












to	 inhibit	 tumorigenesis,	 does	 not	 take	 place	 in	 human	 uterine	
cancer	 [19].	Alternatively,	 the	 data	 suggest	 that	 in	 endometrial	
carcinoma	 hypermethylation	 of	 the	 genome	 is	 more	 common	
event	than	demethylation.	Moreover,	hypermethylation	of	DNA,	
which	 was	 not	 observed	 in	 the	 well-differentiated	 tumors	 but	








DNA	methylation	 status	 could	 indicate	 a	 low	 risk	 endometrial	







	 Our	 results	 could	 also	 clearly	 indicate	 that	 lower	 total	
DNA	 methylation	 is	 associated	 with	 diminished	 myometrial	










>50%,	 6%-50%	 and	 <5%	 of	 undifferentiated,	 solid	 neoplastic	
cells,	 respectively	 [16].	These	data	 support	 the	 conclusion	 that	
changes	in	the	global	level	of	methylated	cytosine	are	related	to	





	 Although	 local	 changes	 in	 DNA	 methylation	 precede	
malignancy,	our	 results	 indicate	 that	 the	global	changes	appear	
to	be	dependent	on	the	histological	grade	or	invasiveness	of	the	




was	 not	 related	 to	 the	 age	 of	 the	 affected	 women.	 This	 is	 in	




The authors wish to thank Dr. Gérard Keith for the possibility to 
conduct all DNA methylation investigations in his laboratory, and 
critical reading of the manuscript, and for his helpful suggestions, 
too.
References
  1. Pfeifer G, Tang M, Denissenko M. Mutation hotspots and DNA methylation. In: DNA methylation 
and cancer. Ed.	Jones	P,	Vogt	P	Berlin,	Heidelberg:	Springer-Verlag.	2000,	1-19.
  2. 	 Esteller	M,	Herman	J.	Cancer	as	an	epigenetic	disease:	DNA	methylation	and	chromatin	altera-
tions in human tumors. J Pathol. 2002, 196, 1-7.
  3.  Łuczak M, Jagodzinski P. The role of DNA methylation in cancer development. Folia Histochem 
Cytobiol. 2006, 44, 143-154.
  4.  Laird P. Cancer epigenetics. Human Mol Genet. 2005, 14, R65-R76.
  5.  Counts J, Goodman J. Alterations in DNA methylation may play a variety of roles in carcinogen-
esis. Cell. 1995, 83, 13-15.
  6. 	 Gama-Sosa	M,	Slagel	V,	Trewyn	R,	[et	al.].	The	5-methylcytosine	content	of	DNA	from	human	
tumors. Nucleic Acids Res. 1983, 11, 6883-6894.
  7.  Bernardino J, Roux C, Almeida A, [et. al.]. DNA hypomethylation in breast cancer: an indepen-
dent parameter of tumor progression. Cancer Genet Cytogenet. 1997, 97, 83-89.
  8.  Soares J, Pinto A, Cunha C, [et al.]. Global DNA hypomethylation in breast carcinoma: correla-
tion with prognostic factors and tumor progression. Cancer. 1999, 85, 112-118.
  9.  Shen L, Fang J, Qiu D, [et al.]. Correlation between DNA methylation and pathological changes 
in human hepatocellular carcinoma. Hepatogastroenterology. 1998, 45, 1753-1759.
10.		 Lin	C,	Hsieh	S,	Sheen	I,	[et	al.].	Genome-wide	hypomethylation	in	hepatocellular	carcinogen-
esis. Cancer Res. 2001, 61, 4238-4243.
11.		 Bedford	M,	van	Helden	P.	Hypomethylation	of	DNA	in	pathological	conditions	in	human	prostate.	
Cancer Res. 1987, 47, 5274-5276.
12.  Popiela A, Gabryś M, Rabczyński J, [et al.]. Estimation of DNA methylation level in endometrial 
cancer tissues. Ginekol Pol. 2002, 73, 966-969. Polish.
13.		 Kliasheva	R,	Volkov	V,	Panfilova	G.	Nucleotide	composition	and	the	methylated	cytosine	level	in	
the DNA from cancerous stomach tumor. Vopr Onkol. 1980, 26, 45-48. Russian.
14.  Kliasheva R. DNA methylation in human lung tumors. Vopr Onkol. 1990, 36, 1186-1189. Rus-
sian.
15.  Wajed S, Laird P, DeMeester T. DNA methylation: an alternative pathway to cancer. Ann Surg. 
2001, 234, 10-20.
16.  Postawski K, Keith G, Semczuk A, [et al.]. Total DNA methylation in human normal endometrium 
depends on the menstrual cycle phase. Pol J Gyn Invest. 2001, 4, 73-77.
17.  Scully R, Bonfiglio T, Kurman R, [et al.]. Definitions and explanatory notes. Uterine corpus. 1 




hMSH2	protein	 immunoreactivity	 in	sporadic	human	endometrial	carcinomas.	 Int J Mol Med. 
2003, 11, 569-574.
19.  MacLeod A, Szyf M. Expression of antisense to DNA methyltransferase mRNA induces DNA 
demethylation and inhibits tumorigenesis. J Biol Chem. 1995, 270, 8037-8043.
20. Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol. 2004, 35, 649-662.
21.		 Goelz	S,	Vogelstein	B,	Hamilton	S,	[et	al.].	Hypomethylation	of	DNA	from	benign	and	malignant	
human colon neoplasms. Science. 1985, 228, 187-190.
22.  Ahuja N, Li Q, Mohan A, [et al.]. Aging and DNA methylation in colorectal mucosa and cancer. 
Cancer Res. 1998, 58, 5489-5494.
